ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.100,17
0,15%
S&P 500
5.473,23
0,77%
Dow Jones
38.778,10
0,00%
Euro vs US Dollar
1,07112
-0,27%
Bitcoin
65.394,33
-1,64%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AlloVir Inc (ALVR)

  7. AlloVir Inc (ALVR) News

ALVR

AlloVir (ALVR)

AlloVir Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ALVR
DatumZeitQuelleÜberschriftSymbolFirma
11/06/202423h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
07/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
07/06/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
03/06/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
23/05/202423h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
22/05/202402h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
21/05/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
18/05/202402h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
13/05/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALVRAlloVir Inc
07/05/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
14/03/202411h10PR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
07/03/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVRNASDAQ:ALVRAlloVir Inc
22/02/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
22/02/202411h45PR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
22/02/202402h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
20/02/202423h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
15/02/202422h30Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ALVRAlloVir Inc
12/02/202422h34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
09/02/202411h45PR Newswire (US)Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:ALVRAlloVir Inc
06/02/202422h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
06/02/202402h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
02/02/202411h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
26/01/202411h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
25/01/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
24/01/202402h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
09/01/202418h32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALVRAlloVir Inc
09/01/202418h29Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALVRAlloVir Inc
08/01/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
05/01/202412h14IH Market NewsWall Street Highlights: Google Rejects Union Negotiations, Exxon Mobil Announces $2.5 Billion Accounting Write-Down in CaliforniaNASDAQ:ALVRAlloVir Inc
05/01/202400h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
 Showing the most relevant articles for your search:NASDAQ:ALVR

Kürzlich von Ihnen besucht

USOTC
TERNF
Tern (PK)
COIN
SETTTUSD
Setter Protocol
ASX
LU7
Lithium Universe
USOTC
MRETF
Martinrea (PK)
BOV
BIOM3F
BIOMM ON
TG
A3H2X1
Adidas
LBNK
MXUSDT
MX Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten